MX2010000474A - Inhibidores de proteina serina/treonina quinasa a/proteina quinasa b con actividad antitumoral. - Google Patents

Inhibidores de proteina serina/treonina quinasa a/proteina quinasa b con actividad antitumoral.

Info

Publication number
MX2010000474A
MX2010000474A MX2010000474A MX2010000474A MX2010000474A MX 2010000474 A MX2010000474 A MX 2010000474A MX 2010000474 A MX2010000474 A MX 2010000474A MX 2010000474 A MX2010000474 A MX 2010000474A MX 2010000474 A MX2010000474 A MX 2010000474A
Authority
MX
Mexico
Prior art keywords
akt
compound
subject invention
cell
pkb
Prior art date
Application number
MX2010000474A
Other languages
English (en)
Spanish (es)
Inventor
Said M Sebti
Jin Q Cheng
Mei Sun
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Publication of MX2010000474A publication Critical patent/MX2010000474A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2010000474A 2007-07-12 2008-07-14 Inhibidores de proteina serina/treonina quinasa a/proteina quinasa b con actividad antitumoral. MX2010000474A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94936507P 2007-07-12 2007-07-12
PCT/US2008/069974 WO2009009793A2 (en) 2007-07-12 2008-07-14 Inhibitors of akt/pkb with anti-tumor activity

Publications (1)

Publication Number Publication Date
MX2010000474A true MX2010000474A (es) 2010-06-23

Family

ID=40229514

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000474A MX2010000474A (es) 2007-07-12 2008-07-14 Inhibidores de proteina serina/treonina quinasa a/proteina quinasa b con actividad antitumoral.

Country Status (10)

Country Link
US (2) US8183249B2 (enExample)
EP (1) EP2173352B1 (enExample)
JP (1) JP5568471B2 (enExample)
KR (1) KR101618037B1 (enExample)
CN (1) CN101743007B (enExample)
AU (1) AU2008274956B2 (enExample)
BR (1) BRPI0815563A2 (enExample)
CA (1) CA2695330C (enExample)
MX (1) MX2010000474A (enExample)
WO (1) WO2009009793A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101052640B (zh) * 2004-09-03 2011-05-11 默克雪兰诺有限公司 吡啶亚甲基唑烷酮类及其作为磷酸肌醇抑制剂的用途
CA2695330C (en) * 2007-07-12 2017-06-13 University Of South Florida Inhibitors of akt/pkb with anti-tumor activity
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (en) 2010-09-07 2013-10-23 Dmi Acquisition Corp TREATMENT OF DISEASES
WO2012158197A2 (en) * 2010-11-11 2012-11-22 Lyndor Biosciences L.L.C. Compounds useful as akt/pkb modulators and uses thereof
PL2694959T3 (pl) * 2011-04-01 2020-05-18 Genentech, Inc. Biomarkery do przewidywania wrażliwości w leczeniu nowotworu złośliwego
WO2012135781A1 (en) 2011-04-01 2012-10-04 Genentech, Inc. Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
CN102225067B (zh) * 2011-04-29 2012-10-03 济南环肽医药科技有限公司 一种治疗胃癌的药物组合物
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
EP2771007B1 (en) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
GB201207722D0 (en) * 2012-05-02 2012-06-13 Bergenbio As Method
KR101461626B1 (ko) * 2012-08-02 2014-11-28 서울대학교산학협력단 Ａｋｔ１ 억제제 및 소수성 항암제를 포함하는 항암용 약학적 조성물
WO2014074883A1 (en) * 2012-11-08 2014-05-15 Lyndor Biosciences L.L.C. Novel synthesis of ld101
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
CN112472699A (zh) 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法
US9986375B2 (en) * 2014-02-12 2018-05-29 Google Llc Energy-efficient location determination
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
FR3033499A1 (fr) * 2015-03-11 2016-09-16 Centre Leon-Berard Composition pour le traitement des tumeurs neuroendocrines pancreatiques
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN116650645A (zh) * 2020-12-04 2023-08-29 周清华 Akt/stat3作为免疫检查点抑制剂的靶点的用途
EP4486390A1 (en) * 2022-03-02 2025-01-08 Terremoto Biosciences, Inc Covalent modifiers of akt1 and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US5167649A (en) 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
JP4407008B2 (ja) * 2000-05-11 2010-02-03 パナソニック株式会社 カラー画像形成装置
UA72612C2 (en) 2000-07-06 2005-03-15 Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
US20040063658A1 (en) 2002-05-06 2004-04-01 Roberts Christopher Don Nucleoside derivatives for treating hepatitis C virus infection
MXPA06011219A (es) * 2004-03-29 2007-05-08 Univ South Florida Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados.
US8828451B2 (en) * 2006-10-04 2014-09-09 University Of South Florida Akt sensitization of cancer cells
CA2695330C (en) * 2007-07-12 2017-06-13 University Of South Florida Inhibitors of akt/pkb with anti-tumor activity

Also Published As

Publication number Publication date
KR20100066438A (ko) 2010-06-17
AU2008274956A1 (en) 2009-01-15
CN101743007B (zh) 2015-04-08
US20090028855A1 (en) 2009-01-29
EP2173352A4 (en) 2011-07-27
CN101743007A (zh) 2010-06-16
WO2009009793A2 (en) 2009-01-15
AU2008274956B2 (en) 2014-08-21
BRPI0815563A2 (pt) 2015-02-18
EP2173352A2 (en) 2010-04-14
JP5568471B2 (ja) 2014-08-06
CA2695330A1 (en) 2009-01-15
KR101618037B1 (ko) 2016-05-04
US8183249B2 (en) 2012-05-22
WO2009009793A3 (en) 2009-03-26
JP2010533206A (ja) 2010-10-21
EP2173352B1 (en) 2016-09-07
US20130034598A1 (en) 2013-02-07
US9359347B2 (en) 2016-06-07
CA2695330C (en) 2017-06-13

Similar Documents

Publication Publication Date Title
MX2010000474A (es) Inhibidores de proteina serina/treonina quinasa a/proteina quinasa b con actividad antitumoral.
UA110697C2 (uk) ЗАСТОСУВАННЯ ІНГІБІТОРІВ TOR-КІНАЗИ ДЛЯ ЛІКУВАННЯ ПУХЛИННИХ ЗАХВОРЮВАНЬ У ПАЦІЄНТА ЗІ ЗНИЖЕНИМ РІВНЕМ БІЛКА pAMPK ТА/АБО АКТИВНОСТІ AMPK
EP2134346A4 (en) INHIBITORS OF JANUS KINASES AND / OR 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1
EA201100119A1 (ru) Химические соединения 251
MX2009009304A (es) Inhibidores de cinasa pim y metodos para su uso.
TW200626576A (en) Bicyclic amides as kinase inhibitors
TW200801008A (en) Protein kinase inhibitors
EA201391682A1 (ru) Замещенные производные индазола, активные в качестве ингибиторов киназы
MY152948A (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
MY150136A (en) Picolinamide derivatives as kinase inhibitors
MX2017004128A (es) Derivados de diarilurea como inhibidores de quinasa p38.
IL174965A0 (en) SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF Raf KINASE
UA116187C2 (uk) ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ
EA201100580A1 (ru) Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA200600689A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов raf киназы
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
EA201070611A1 (ru) Ингибиторы человеческой фосфатидилинозитол-3-киназы дельта
PH12020552135A1 (en) Kdm1a inhibitors for the treatment of disease
MX2009006688A (es) Compuestos y metodos para modulacion de cinasas, e indicaciones para ello.
EA200901488A1 (ru) Замещенные имидазолопиридазины, как ингибиторы липидкиназы
AU2011338389A8 (en) Bicyclic compounds as Pim inhibitors
EA201890768A3 (ru) Лечение злокачественной опухоли ингибиторами tor-киназы
PH12012502070A1 (en) Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
UA84954C2 (ru) Конденсированные пиримидоны, пригодные для лечения и профилактики злокачественного новообразования
EA201071422A1 (ru) Способы лечения заболеваний, связанных с мейотическим кинезином

Legal Events

Date Code Title Description
FG Grant or registration